Hiroyuki Murai

机构：International University of Health and Welfare · ORCID：0000-0003-1612-1440

发表论文 328 篇 · 总被引 10507 次 · h-index 46

代表论文

Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial (2025 · The Lancet Neurology · 被引 35)
Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases (2025 · Expert Review of Clinical Immunology · 被引 26)
Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis (2024 · Frontiers in Immunology · 被引 10)
Worsening of myasthenic symptoms associated with statins (2024 · Journal of the Neurological Sciences · 被引 6)
Comparative study of Japanese nationwide epidemiological studies of myasthenia gravis using datasets of 2006 and 2018 (2025 · PLoS ONE · 被引 2)
Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry (2025 · Clinical and Experimental Neuroimmunology · 被引 2)